Cytovale Completes $100 Million Series D Funding to Accelerate Commercial Expansion of Its Rapid Sepsis Solution
Cytovale
IntelliSep is the first and only FDA-cleared cellular host diagnostic indicated for use in the ED
Sepsis
ADLM 2024 Highlights Point-of-Care and Sepsis Innovations
Tyler Radke, MLS(ASCP)CM
First-time attendee explores new technologies and future solutions at the Association for Diagnostics in Laboratory Medicine Annual Lab Expo
New Rapid Detection of Bacteria in Pediatric Blood Samples
American Society for Microbiology
Researchers are testing a new technology to diagnose bacteremia in newborn babies
New Sepsis Test Could Save Lives and Costs in Hospitals
Penn State
The test may prevent clinicians from relying solely on their judgement to treat a patient presenting sepsis symptoms
3 Ways Medical Lab Professionals Can Improve Sepsis Survival Rates
Robert Scoggins, MD, PhD
As many as 80 percent of deaths due to sepsis could be avoided through rapid diagnosis and treatment
Researchers Develop Shortcut to Detect and Identify Known, Emerging Pathogens
McMaster University
Scientists have developed a sophisticated new tool that could help provide early warning of rare and unknown viruses
NIH Grant to Develop Biotechnology to Better Detect Sepsis
Rochester Institute of Technology
New nanodevice could detect drug-resistant bacteria faster and more accurately, increasing chances of recovery
COVID-19 and Sepsis: Risk-Stratifying Patients Based on Their Immune Response
Timothy E. Sweeney, MD, PhD
Host-response diagnostics that “read” the immune response can help clinicians make better, faster treatment decisions
Severe Sepsis Predicted by Common Protein
University of Connecticut
Sugar-binding protein galectin-1 could be a biomarker for patients at risk of life threatening sepsis
Milestone for the Early Detection of Sepsis
Graz University of Technology
Groundbreaking method uses biomarkers to detect sepsis two to three days before the first clinical symptoms appear